CC

Cynthia Monesa Clark

AT Aerpio Therapeutics: 11 patents #3 of 19Top 20%
The Procter & Gamble: 3 patents #3,571 of 10,133Top 40%
WC Warner Chilcott Company: 2 patents #15 of 62Top 25%
AP Aerpio Pharmaceuticals: 1 patents #3 of 10Top 30%
📍 Concord, MA: #94 of 720 inventorsTop 15%
🗺 Massachusetts: #6,946 of 88,656 inventorsTop 8%
Overall (All Time): #276,092 of 4,157,543Top 7%
17
Patents All Time

Issued Patents All Time

Showing 1–17 of 17 patents

Patent #TitleCo-InventorsDate
10463650 Human protein tyrosine phosphatase inhibitors and methods of use Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Ryan Matthew Nichols, Matthew B. Maier 2019-11-05
RE46592 Human protein tyrosine phosphatase inhibitors and methods of use Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Ryan Matthew Nichols, Matthew B. Maier 2017-10-31
9795594 Human protein tyrosine phosphatase inhibitors and methods of use Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Ryan Matthew Nichols, Matthew B. Maier 2017-10-24
9284285 Human protein tyrosine phosphatase inhibitors and methods of use Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Ryan Matthew Nichols, Matthew B. Maier 2016-03-15
9126958 Human protein tyrosine phosphatase inhibitors and methods of use Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Ryan Matthew Nichols, Matthew B. Maier 2015-09-08
8946232 Human protein tyrosine phosphatase inhibitors and methods of use Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Ryan Matthew Nichols, Matthew B. Maier 2015-02-03
8895563 Human protein tyrosine phosphatase inhibitors and methods of use Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Ryan Matthew Nichols, Matthew B. Maier 2014-11-25
8846685 Human protein tyrosine phosphatase inhibitors and methods of use Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Ryan Matthew Nichols, Matthew B. Maier 2014-09-30
8338615 Human protein tyrosine phosphatase inhibitors and methods of use Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Ryan Matthew Nichols, Matthew B. Maier 2012-12-25
8329916 Human protein tyrosine phosphatase inhibitors and method of use Kande K. D. Amarasinghe, Ryan Matthew Nichols, Matthew B. Maier, Jeffrey Lyle Gray 2012-12-11
8258311 Human protein tyrosine phosphatase inhibitors and methods of use Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Ryan Matthew Nichols, Matthew B. Maier 2012-09-04
8188125 Human protein tyrosine phosphatase inhibitors and methods of use Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Ryan Matthew Nichols, Matthew B. Maier 2012-05-29
8106078 Human protein tyrosine phosphatase inhibitors and methods of use Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Ryan Matthew Nichols, Matthew B. Maier 2012-01-31
7795444 Human protein tyrosine phosphatase inhibitors and methods of use Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Ryan Matthew Nichols, Matthew B. Maier 2010-09-14
7622593 Human protein tyrosine phosphatase inhibitors and methods of use Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Ryan Matthew Nichols, Matthew B. Maier 2009-11-24
7589212 Human protein tyrosine phosphatase inhibitors and methods of use Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Ryan Matthew Nichols, Matthew B. Maier 2009-09-15
6677337 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines Matthew John Laufersweiler, Michael P. Clark, Jane Far-Jine Djung, Biswanath De, Michael G. Natchus 2004-01-13